- Home
- SRPT vs GEL Comparison
SRPT vs GEL Comparison
Compare SRPT & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRPT | GEL |
|---|---|---|
| Founded | 1980 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2000 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SRPT | GEL |
|---|---|---|
| Price | $19.18 | $14.24 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 24 | 3 |
| Target Price | ★ $21.64 | $18.00 |
| AVG Volume (30 Days) | ★ 2.7M | 214.9K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 5.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.99 | 0.21 |
| Revenue | $2,198,237,000.00 | ★ $2,912,770,000.00 |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $6.25 | $68.40 |
| Revenue Growth | 15.58 | ★ 43.60 |
| 52 Week Low | $14.68 | $13.55 |
| 52 Week High | $24.68 | $18.64 |
Technical Indicators
Market Signals| Indicator | SRPT | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 54.79 | 47.67 |
| Support Level | $18.38 | $13.65 |
| Resistance Level | $19.71 | $14.61 |
| Average True Range (ATR) | 0.94 | 0.30 |
| MACD | 0.21 | 0.07 |
| Stochastic Oscillator | 82.72 | 60.47 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.
About GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.